Rockwell Medical Technologies Schedules Conference Call Reporting Second Quarter Results

WIXOM, Mich., July 26, 2012 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis, announced today that it will hold an investor conference call on Tuesday, August 7, 2012 at 8:30 a.m. ET to discuss its second quarter 2012 results. Robert Chioini, Chairman and CEO, and Thomas Klema, CFO, will be hosting the call to review Rockwell's results. Rockwell will be releasing the earnings results on the same date.